ESR1 and breast cancer: To substantiate this observation, wild-type FOXP3 was transfected into breast cancer cell lines T47D (ER+, PR+, HER2-) and MDA-MB-231 (ER-, PR-, HER2-), which have low expression of FOXP3 [36].